GGrantIndex
Sort

64,565 grants matching drug discovery

Research Training in Chemistry and Chemical Biology

$636,642
Jason E Gestwicki · University Of California, San Francisco · T32 · FY2023 · GM

Interdepartmental Training in Pharmacological Sciences

$636,642
Lori L Isom · University Of Michigan At Ann Arbor · T32 · FY2023 · GM

Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications

$636,596
Ann Marie Schmidt · New York University School Of Medicine · R01 · FY2021 · DK

Microbial Ecology-Guided Discovery of Antibacterial Drugs

$636,497
Eric W Schmidt · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI

Defining the targets of broad intervention antimalarial agents

$636,473
Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2016 · AI

Lead optimization of DHODH inhibitors for malaria

$636,297
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2013 · AI

Development of P2Y Receptor Ligands

$636,265
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Dissecting triazole resistance and transcriptional regulation of ergosterol homeo

$636,244
Haoping Liu · University Of California-Irvine · R01 · FY2014 · AI

Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer

$636,146
David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA

Automated high throughput compound screening for broadly active anti-parasitic nematode drugs

$636,142
Raffi V Aroian · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI

Discovery and Assessment of Genetic Determinants of HCV and HIV Control

$636,115
Raymond T Chung · Massachusetts General Hospital · R01 · FY2015 · DA

Autoantibodies Define Scleroderma Subgroups with Distinct Relationships to Cancer

$636,081
Ami Aalok Shah · Johns Hopkins University · R01 · FY2020 · AR

HTS Targeting HIV-1 Protease Autoprocessing for First in Class Drug Discovery

$636,059
Chaoping Chen · Colorado State University · R01 · FY2021 · AI

High Throughput Intracellular Drug Screening Platform

$635,981
Cristian Ionescu-Zanetti · Fluxion Biosciences, Inc. · R44 · FY2007 · GM

Chemical Biology of the Control of Neddylation by DCN1

$635,945
R Kiplin Guy · University Of Kentucky · R01 · FY2021 · CA

Chemical Biology of the Control of Neddylation by DCN1

$635,943
R Kiplin Guy · University Of Kentucky · R01 · FY2020 · CA

Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations

$635,940
Keoki Williams · Henry Ford Health System · R01 · FY2020 · DK

Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons

$635,925
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2025 · NS

Novel small-molecule therapies for CF

$635,784
Alan S Verkman · University Of California, San Francisco · P30 · FY2022 · DK

Novel Therapy to Inhibit IPMN Progression

$635,784
Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA

Retrovirus Evolution

$635,763
John M Coffin · Tufts University Boston · R37 · FY2007 · CA

Stereoselective Atom Transfer

$635,754
K Barry Sharpless · Scripps Research Institute, The · R01 · FY2006 · GM

PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-

$635,712
Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2021 · CA

Stereoselective Atom Transfer

$635,706
K Barry Sharpless · Scripps Research Institute, The · R01 · FY2007 · GM

Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice

$635,706
Mary Jo Ladu · University Of Illinois At Chicago · R01 · FY2020 · AG